{"id":"https://openalex.org/W2147394591","doi":"https://doi.org/10.1200/jco.2004.08.116","title":"Safety and Pharmacokinetics of Escalated Doses of Weekly Intravenous Infusion of CCI-779, a Novel mTOR Inhibitor, in Patients With Cancer","display_name":"Safety and Pharmacokinetics of Escalated Doses of Weekly Intravenous Infusion of CCI-779, a Novel mTOR Inhibitor, in Patients With Cancer","publication_year":2004,"publication_date":"2004-05-11","ids":{"openalex":"https://openalex.org/W2147394591","doi":"https://doi.org/10.1200/jco.2004.08.116","mag":"2147394591","pmid":"https://pubmed.ncbi.nlm.nih.gov/15136596"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.08.116","doi":"https://doi.org/10.1200/jco.2004.08.116","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2004.08.116","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.08.116?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2147394591"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.08.116?role=tab","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013952219","display_name":"\u00c9ric Raymond","orcid":"https://orcid.org/0000-0001-5491-2708","observed_orcids":["https://orcid.org/0000-0001-5491-2708"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Eric Raymond","raw_affiliation_strings":["From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091487792","display_name":"J\u00e9r\u00f4me Alexandre","orcid":"https://orcid.org/0000-0001-5252-5800","observed_orcids":["https://orcid.org/0000-0001-5252-5800"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"J\u00e9r\u00f4me Alexandre","raw_affiliation_strings":["From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002864173","display_name":"Sandrine J. Faivre","orcid":"https://orcid.org/0000-0002-1590-485X","observed_orcids":["https://orcid.org/0000-0002-1590-485X"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Sandrine Faivre","raw_affiliation_strings":["From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061964124","display_name":"Karina Vera","orcid":"https://orcid.org/0000-0003-2669-4285","observed_orcids":["https://orcid.org/0000-0003-2669-4285"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Karina Vera","raw_affiliation_strings":["From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080305589","display_name":"Eric Materman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Eric Materman","raw_affiliation_strings":["From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017509777","display_name":"Joseph P Boni","orcid":"https://orcid.org/0000-0003-0228-0213","observed_orcids":["https://orcid.org/0000-0003-0228-0213"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Joseph Boni","raw_affiliation_strings":["From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065204018","display_name":"Cathie A. Leister","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Cathie Leister","raw_affiliation_strings":["From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050194925","display_name":"Joan M Korth-Bradley","orcid":"https://orcid.org/0000-0003-2436-9833","observed_orcids":["https://orcid.org/0000-0003-2436-9833"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Joan Korth-Bradley","raw_affiliation_strings":["From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080284239","display_name":"Axel-Rainer Hanauske","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Axel Hanauske","raw_affiliation_strings":["From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109930287","display_name":"Jean\u2010Pierre Armand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Jean-Pierre Armand","raw_affiliation_strings":["From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Gustave Roussy Institute, Villejuif, France; Onkologische Tagesklinik, Munich, Germany; and Wyeth, Collegeville, PA","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4403928396"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":11.8364,"has_fulltext":true,"cited_by_count":505,"citation_normalized_percentile":{"value":0.99523733,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"22","issue":"12","first_page":"2336","last_page":"2347"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.7570000290870667},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.9210000038146973},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7549999952316284},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8820000290870667},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8220000267028809},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8930000066757202},{"id":"https://openalex.org/keywords/nonlinear-clearance","display_name":"nonlinear clearance","score":0.5960000157356262},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.6579999923706055},{"id":"https://openalex.org/keywords/clear-cell-renal-cell-carcinoma","display_name":"clear cell renal cell carcinoma","score":0.7229999899864197},{"id":"https://openalex.org/keywords/breast-adenocarcinoma","display_name":"breast adenocarcinoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/anticancer-drug-toxicity","display_name":"anticancer drug toxicity","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9027824997901917},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7938805818557739},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.7366076707839966},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.607250452041626},{"id":"https://openalex.org/C2779051857","wikidata":"https://www.wikidata.org/wiki/Q911386","display_name":"Stomatitis","level":2,"score":0.5723647475242615},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4798007309436798},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4757879972457886},{"id":"https://openalex.org/C2777921159","wikidata":"https://www.wikidata.org/wiki/Q32089","display_name":"Sirolimus","level":2,"score":0.46296170353889465},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.4567921459674835},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.44293180108070374},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4096388816833496},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3528670072555542},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3510885536670685}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007109","descriptor_name":"Immunity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.08.116","doi":"https://doi.org/10.1200/jco.2004.08.116","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2004.08.116","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.08.116?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:15136596","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15136596","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1200/jco.2004.08.116","doi":"https://doi.org/10.1200/jco.2004.08.116","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2004.08.116","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.08.116?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2147394591.pdf","grobid_xml":"https://content.openalex.org/works/W2147394591.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W88453891","https://openalex.org/W1593019308","https://openalex.org/W1599727238","https://openalex.org/W1969443259","https://openalex.org/W1973771269","https://openalex.org/W1976350400","https://openalex.org/W1979819215","https://openalex.org/W1985046929","https://openalex.org/W1988609792","https://openalex.org/W1993860023","https://openalex.org/W2007276247","https://openalex.org/W2011485783","https://openalex.org/W2026351725","https://openalex.org/W2039171689","https://openalex.org/W2039633811","https://openalex.org/W2057709162","https://openalex.org/W2058829665","https://openalex.org/W2064661688","https://openalex.org/W2075421237","https://openalex.org/W2076108528","https://openalex.org/W2078689449","https://openalex.org/W2102648794","https://openalex.org/W2118187735","https://openalex.org/W2119151792","https://openalex.org/W2123664371","https://openalex.org/W2125861971","https://openalex.org/W2126314379","https://openalex.org/W2133368517","https://openalex.org/W2135836172","https://openalex.org/W2139505545","https://openalex.org/W2141825683","https://openalex.org/W2142506125","https://openalex.org/W2148842373","https://openalex.org/W2151414214","https://openalex.org/W2151709942","https://openalex.org/W2158612356","https://openalex.org/W2172159375"],"related_works":["https://openalex.org/W2566797763","https://openalex.org/W2150937214","https://openalex.org/W2151709942","https://openalex.org/W2139482461","https://openalex.org/W2107973201","https://openalex.org/W2415587511","https://openalex.org/W2129539865","https://openalex.org/W2590933486","https://openalex.org/W1827578754","https://openalex.org/W2586469457"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"establish":[2],"the":[3,15,127,220],"safety,":[4],"tolerability,":[5],"and":[6,91,111,124,195,210,233,256],"pharmacokinetic":[7,40],"parameters":[8],"of":[9,14,18,42,87,95,137,230,242],"CCI-779,":[10],"a":[11,29,36,46,146],"selective":[12],"inhibitor":[13],"mammalian":[16],"target":[17],"rapamycin,":[19],"in":[20,73,93,188,196,248,252],"patients":[21,55,75,253],"with":[22,39,132,172,177,191,199,208,254],"advanced":[23],"cancer.":[24,258],"PATIENTS":[25],"AND":[26],"METHODS:":[27],"Using":[28],"modified":[30],"continuous":[31],"reassessment":[32],"method,":[33],"we":[34],"performed":[35],"phase":[37,249],"I":[38],"study":[41],"CCI-779":[43,57,203,236],"given":[44],"as":[45],"weekly":[47,228],"30":[48],"minutes":[49],"intravenous":[50],"(I.V.)":[51],"infusion.":[52],"RESULTS:":[53],"Twenty-four":[54],"received":[56],"at":[58,76,214],"doses":[59,174,215,229],"ranging":[60,160],"7.5":[61],"to":[62,142,153,163,167,217],"220":[63,82,168,218],"mg/m(2).":[64,80],"No":[65],"immunosuppressive":[66,206],"effect":[67],"was":[68,145,158],"reported.":[69],"Dose-limiting":[70],"thrombocytopenia":[71],"occurred":[72],"two":[74,94],"34":[77],"or":[78,113],"45":[79],"At":[81],"mg/m(2),":[83,219],"dose-limiting":[84],"toxicities":[85,106,116],"consisted":[86],"manic-depressive":[88],"syndrome,":[89],"stomatitis,":[90],"asthenia":[92],"nine":[96],"patients,":[97],"preventing":[98],"further":[99],"dose":[100,222,244],"escalation.":[101],"The":[102],"most":[103],"frequent":[104],"drug-related":[105],"were":[107,117,186],"acne-like,":[108],"maculopapular":[109],"rashes":[110],"mucositis":[112],"stomatitis.":[114],"All":[115],"reversible":[118,211],"on":[119,180,225,239],"treatment":[120],"discontinuation.":[121],"Maximum":[122],"concentration":[123],"area":[125],"under":[126],"concentration-time":[128],"curve":[129],"increase":[130],"sub-proportionally":[131],"dose.":[133],"Mean":[134],"steady-state":[135],"volume":[136],"distribution":[138],"ranged":[139],"from":[140,161],"127":[141],"385L.":[143],"Sirolimus":[144],"major":[147],"metabolite":[148],"(metabolite-to-parent":[149],"ratio":[150],"range,":[151],"2.5":[152],"3.5).":[154],"Whole":[155],"blood":[156],"clearance":[157],"nonlinear,":[159],"19":[162],"51":[164],"L/h":[165],"(34":[166],"mg/m(2)).":[169],"Variability":[170],"predicted":[171],"flat":[173],"appears":[175],"comparable":[176],"data":[178],"based":[179,238],"body-surface":[181],"area-normalized":[182],"treatment.":[183],"Partial":[184],"responses":[185],"observed":[187],"one":[189,197],"patient":[190,198],"renal":[192,257],"clear-cell":[193],"carcinoma":[194],"breast":[200,255],"adenocarcinoma.":[201],"CONCLUSION:":[202],"displayed":[204],"no":[205],"effects":[207],"manageable":[209],"adverse":[212],"events":[213],"up":[216],"highest":[221],"tested.":[223],"Based":[224],"our":[226],"results,":[227],"25,":[231],"75,":[232],"250":[234],"mg":[235],"not":[237],"classical":[240],"definitions":[241],"maximum-tolerated":[243],"are":[245],"being":[246],"tested":[247],"II":[250],"trials":[251]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":18},{"year":2013,"cited_by_count":29},{"year":2012,"cited_by_count":40}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}